Absorption |
Blood-Brain Barrier | BBB+ | 0.9657 |
Human Intestinal Absorption | HIA+ | 0.9867 |
Caco-2 Permeability | Caco2+ | 0.8092 |
P-glycoprotein Substrate | Non-substrate | 0.6103 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9618 |
Non-inhibitor | 0.9651 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9360 |
Distribution |
Subcellular localization | Mitochondria | 0.5379 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7728 |
CYP450 2D6 Substrate | Non-substrate | 0.8966 |
CYP450 3A4 Substrate | Non-substrate | 0.6955 |
CYP450 1A2 Inhibitor | Inhibitor | 0.8055 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8977 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9504 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9474 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9531 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9587 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9515 |
Non-inhibitor | 0.8971 |
AMES Toxicity | Non AMES toxic | 0.9850 |
Carcinogens | Non-carcinogens | 0.6359 |
Fish Toxicity | High FHMT | 0.7928 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9766 |
Honey Bee Toxicity | High HBT | 0.6652 |
Biodegradation | Ready biodegradable | 0.8962 |
Acute Oral Toxicity | III | 0.8226 |
Carcinogenicity (Three-class) | Non-required | 0.6773 |